IO University

    LUNG CANCER

    Lung cancer is the leading cause of cancer death in the United States and is most often associated with cigarette smoking, though other causes have been identified. Because many people have no symptoms until the disease has metastasized, screening is recommended for groups at higher risk because of older-age and smoking history. Early detection and classification of lung cancer, with staging to guide selection of interventions, can greatly improve patient outcomes. Recent advances in lung cancer treatment include minimally-invasive-surgical and radiofrequency-ablative techniques, targeted therapies, and immunotherapies.

    Online modules have been approved for AMA PRA Category 1 Credit(s)™

    COMMERCIAL SUPPORT ACKNOWLEDGMENT

    This activity is supported by an educational grant from Bayer Healthcare, Biocompatibles, Inc., Boston Scientific, Guerbet LLC, and Medical Device Business Services, Inc. (Ethicon).

     

    Lung Cancer Screening

    Upon completion of the activity, participants should be able to:

    • Review historical RCTs of lung cancer screening
    • Explore the purpose and utility of the ACR Lung – RADSTM
    • Identify individuals that may benefit from lung cancer screening

     

    In order to view the IO Online University products, you must create an IO-Central website account.

    Create an account

    If you already have an account, click here to login.

     

    Staging and Diagnosis of Lung Cancer

    Upon completion of the activity, participants should be able to:

    • Discuss the role of imaging in lung cancer diagnosis and staging
    • Review descriptors identified in the 8th Edition of TNM Staging for Lung Cancer
    • Review methods for tissue acquisition for lung cancer diagnosis and mediastinal staging

     

    In order to view the IO Online University products, you must create an IO-Central website account.

    Create an account

    If you already have an account, click here to login.

    Image-Guided Thermal Ablation of Lung Cancer

    Upon completion of the activity, participants should be able to:

    • Explore recognized standards of care for thermal ablation of NSCLC as reflected in relevanttreatment guidance, with special attention to imaging-related concerns and combination of IO and conventional treatment
    • Review clinical trial data describing efficacy and safety of ablative therapies

    In order to view the IO Online University products, you must create an IO-Central website account.

    Create an account

    If you already have an account, click here to login.

     

     




    Lung Cancer Pathology: From Atypical Adenomatous Hyperplasia to Adenocarcinoma

    Upon completion of the activity, participants should be able to:

    • Explore lung adenocarcinoma classification, with a focus on the transition from pre-invasive to invasive adenocarcinoma
    • Examine how imaging and molecular testing inform histologic findings in lung adenocarcinoma classification and comprehension of the transition from pre-invasive to invasive disease
    • Describe data supporting this carcinoma progression paradigm

    In order to view the IO Online University products, you must create an IO-Central website account.

    Create an account

    If you already have an account, click here to login.




    Standard of Care Treatment Algorithms (Chemotherapy/Immunotherapy)

    Upon completion of the activity, participants should be able to:

    • Review the current treatment algorithms for lung cancer
    • Identify appropriate roles for systemic therapy in various stages of lung cancer
    • Explain tumor-specific factors that influence selection of systemic treatment modalities

    In order to view the IO Online University products, you must create an IO-Central website account.

    Create an account

    If you already have an account, click here to login.




    The Role of Surgery for Non-Small Cell Lung Cancer

    Upon completion of the activity, participants should be able to:

    • Explore different surgical approaches to NSCLC
    • Determine the extent of resection required based on patient’s surgical risk and tumor factors
    • Review data from clinical trials examining the role of different surgical strategies of patients with NSCLC

    In order to view the IO Online University products, you must create an IO-Central website account.

    Create an account

    If you already have an account, click here to login.

    coming soon image.JPG

    Conventional and Stereotactic Radiotherapy for Lung Cancer

    Upon completion of the activity, participants should be able to:

    • Distinguish the main types of radiation therapy (conventional and stereotactic) used for lung cancer
    • Discuss outcomes for Stage III lung cancer with various conventional treatment approaches
    • Explain recent experience with stereotactic ablative radiotherapy (SAbR), especially for treatment of patients with Stage I tumors
    • Describe ongoing clinical trials examining the use of local therapy (eg, SAbR) in patients with Stage IV lung cancer 

    In order to view the IO Online University products, you must create an IO-Central website account.

    Create an account

    If you already have an account, click here to login.



    Footer

    2025 M Street, NW, Suite 800 | Washington, DC 20036 USA
    (p) +1-202-367-1164 (f) +1-202-367-2164 (e) info@IO-central.org

    Copyright © 2017. All Rights Reserved.